Esperion Therapeutics, Inc.: capex
| Value | {"amount": 19000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dff91522-a6cc-4dad-8f96-26b823ec16cb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-18-000899Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/capex/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dff91522-a6cc-4dad-8f96-26b823ec16cb
History
- no predecessors — first report